Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Aug 14;99(33):e21624.
doi: 10.1097/MD.0000000000021624.

Compound glycyrrhizin combined with antihistamines for chronic urticaria: A protocol for systematic review and meta analysis

Wei Cao  1 , Xianjun Xiao  1   2 , Leixiao Zhang  1 , Ying Liu  1 , Lu Wang  1 , Zihao Zou  1 , Yue Cao  1 , Chunxiao Li  3 , Qianhua Zheng  1 , Siyuan Zhou  1 , Ying Li  1
Affiliations

Compound glycyrrhizin combined with antihistamines for chronic urticaria: A protocol for systematic review and meta analysis

Wei Cao et al. Medicine (Baltimore). .

Abstract

Background: To investigate the efficacy and safety of compound glycyrrhizin (CG) combined with antihistamines in the treatment of chronic urticaria (CU).

Methods: We will use computers to search all databases including Medline, Embase, Pubmed, Web of Science and Cochrane Central Register of Controlled Trials and China's 4 databases: China National Knowledge Infrastructure Database, China Biomedical Literature Database, China Science Journal Database, and Wanfang Database. Find data from creation date to July 2020. In addition, we will manually search the list of medical journals as a supplement. The scope of the search included randomized controlled clinical studies related to CG combined with antihistamines for CU. The primary outcome is the disease activity control. Secondary outcomes include response rate, adverse events, and recurrence rates. The Cochrane RevMan V5.3 Deviation Assessment Tool will be used to assess bias assessment risk, data integration risk, meta-analysis risk, and subgroup analysis risk (if conditions are met). The average difference, standard mean difference, and binary data will be used to represent continuous results.

Results: This study will comprehensively review the existing evidence on CG combined with antihistamines for CU.

Conclusion: This systematic review will provide a basis for judging the effectiveness and safety of CG combined with antihistamines in the treatment of CU.

Systematic review registration: PROSPERO, CRD42020156153.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
The PRISMA flow diagram of the study selection process. PRISMA = preferred reporting items for systematic reviews and meta-analysis protocols.
See this image and copyright information in PMC

References

    1. Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy 2018;73:1393–414. - PubMed
    1. Gaig P, Olona M, Muñoz Lejarazu D, et al. Epidemiology of urticaria in Spain. J Investig Allergol Clin Immunol 2004;14:214–20. - PubMed
    1. Eun SJ, Lee JY, Kim D-Y, et al. Natural course of new-onset urticaria: results of a 10-year follow-up, nationwide, population-based study. Allergol Int 2019;68:52–8. - PubMed
    1. Balp M-M, Vietri J, Tian H, et al. The impact of chronic urticaria from the patient's perspective: a survey in five European countries. Patient 2015;8:551–8. - PMC - PubMed
    1. Confino-Cohen R, Chodick G, Shalev V, et al. Chronic urticaria and autoimmunity: associations found in a large population study. J Allergy Clin Immunol 2012;129:1307–13. - PubMed

MeSH terms